On Tuesday, a Philadelphia jury has awarded $8 billion as compensation for damages against Johnson & Johnson. Johnson & Johnson (J&J), a pharmaceutical company, is facing a lot of verdicts across the globe. Victims worldwide have filed a lawsuit against the famous baby product maker. Besides, the company is striving to settle these cases. Before few months, a Californian jury had awarded $29 million to a lady who claimed asbestos in J&J’s products triggered her cancer. But this time, a man has claimed J&J. Reportedly, a drug, from one of J&J’s subsidiary, has resulted in abnormal growth of female breast tissues in men.
Nicholas Murray, a Maryland-resident, claimed in a verdict that he had experienced gynecomastia after consuming the company’s Risperdal medication between 2003-2008. Risperdal is a medicine often used to treat schizophrenia, a chronic and severe mental illness. The disorder mainly poses a negative impact on a person’s capacity to feel, behave, and think. In childhood, a doctor had prescribed the medicine to Murray as he was finding difficulty in sleeping. Thus after eating the J&J drug for around five years, the man is facing gynecomastia. He has a medical disorder, which results in abnormal growth of breast tissues like women in boys. The verdict claims that the drug manufacturer was aware of the probability of having the disease. Even more, the company has allegedly failed to notify about the risk to healthcare providers and doctors properly.
Before this, in 2015, a jury had formerly awarded $1.75 million as compensation charges to Murray. At that time, the judge had canceled to offer awards under punitive damages citing an international order in a mass tort program. The effort was to adjust with more than 7,000 pending cases of Risperdal in Philadelphia County. Murray is one of the thousands of victims having the same problem in a mass tort case against the company. A mass tort is a civil action that involves many plaintiffs against one or many defendants. But in this case, plaintiffs have to prove the claims individually. Murray has determined how the medicine has harmed him; thus, the jury has awarded $8 billion on account of punitive damages. Above all, J&J is reeling from settling two cases of opioids in Ohio, accounting for more than $20 million.
Kevin has worked as a business executive in an insurance firm before joining Janmorgan Media as the major business correspondent. After joining here, he has helped craft not only some of the insightful articles but also regular articles that don’t compromise perspective. If not checking out business publications or news, you can see her listening to music.